PCa can originate from both luminal and basal cells [16], with alterations in DNA damage response (DDR) genes, such as mutation of the tumour suppressor gene Breast Cancer Gene 2 (BRCA2), being a truncal event in PCa carcinogenesis [15,17]. The gene discussed is BRCA2; the disease is posterior cortical atrophy.